Abbisko Acquires China Rights to Anti-Immunosuppresive Drug from Boston’s X4 Jul 19, 2019 Life Science
EdiGene, a Beijing CRISPR/Cas9 Editing Company, Sells Knockout Cell Line Library to Abcam Jul 18, 2019 Life Science
Philips acquires Boston start-up Medumo to help hospitals communicate with patients Jul 18, 2019 Life Science
I-Mab Announces IND Approval for Its Proprietary TJC4, A Potentially Differentiated CD47 Antibody, to Initiate Clinical Trials in China Jul 16, 2019 Life Science
